Jeff Hunnicutt, CEO of Highlands Oncology Group, discusses the difference between business intelligence and artificial intelligence (AI), including process implementation and data compilation.
In this interview from the Association of Community Cancer Centers’ 49th Annual Meeting and Cancer Center Business Summit, Jeff Hunnicutt, CEO of Highlands Oncology Group, discusses the difference between business intelligence (BI) and artificial intelligence (AI), including process implementation and data compilation.
Transcript
Can you discuss what BI-enabled technology is and how it is used?
BI technology is business intelligence. Essentially, it's advanced internal analytics inside of your practice. Many applications that we deal with on a daily basis, we'll have kind of canned reports that will sit inside. They are useful inside of that application, but frequently, you want to be able to answer more difficult and advanced questions that involve multiple data sources. Business intelligence allows you to grab those data elements from different data sources, bring them into 1 platform, and then throw a visualization tool on top of that so that you can answer more complex questions and really be more efficient running your practice.
How does BI data analytics differ from AI, and what are the potential implications for oncology?
Compilation of data for business intelligence is a much easier endeavor than, say, [AI]. Now, AI is kind of an umbrella term where you have a lot of different technologies that sit underneath that, but the more advanced components of AI—things like deep learning—those take months, if not years, to even compile the amount of data and then have the engine ingest it and figure out what to do with it.
BI, you're gonna have an upfront lift of, say, interfacing technologies to get them into a central repository. But after that, it's really just running the reports and doing your analysis. I'd say it's significantly easier to get BI off the ground than a more complex AI model.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More